Donna Holloway
About
In The Last Decade
Donna Holloway
14 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 2.1k
- Molecular Biology 1.7k
- Orthopedics and Sports Medicine 1.2k
- Rheumatology 371
- Radiology, Nuclear Medicine and Imaging 366
Countries citing papers authored by Donna Holloway
This map shows the geographic impact of Donna Holloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Holloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Holloway more than expected).
Fields of papers citing papers by Donna Holloway
This network shows the impact of papers produced by Donna Holloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Holloway. The network helps show where Donna Holloway may publish in the future.
Co-authorship network of co-authors of Donna Holloway
This figure shows the co-authorship network connecting the top 25 collaborators of Donna Holloway. A scholar is included among the top collaborators of Donna Holloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Holloway. Donna Holloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 13 | |
| 3 | 16 | |
| 4 | Denosumab in Postmenopausal Women with Low Bone Mineral Density breakdown → | 886 |
| 5 | 348 | |
| 6 | 71 | |
| 7 | 4 | |
| 8 | A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women breakdown → | 591 |
| 9 | 295 | |
| 10 | Serum osteoprotegerin levels in healthy controls and cancer patients. | 108 |
| 11 | 379 | |
| 12 | 20 | |
| 13 | 11 | |
| 14 | 72 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.